Literature DB >> 2620171

Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.

C R Andrade1, A E Nascimento, P M Moura, P P Andrade.   

Abstract

The need for a reliable method for the immunological diagnosis of kala-azar is imperative. Leishmania donovani donovani and L. donovani chagasi culture promastigotes were compared as antigens in a direct agglutination test (DAT) for the diagnosis of visceral leishmaniasis in Brazil. Both antigens were successfully employed for the DAT, showing 100% sensitivity and greater than 98% specificity when used to test sera from Brazilian and African kala-azar, Chagas' disease, malaria, filaria and syphilis patients, and on sera from Brazilian controls. Cross-reactions were sometimes observed when cutaneous and mucocutaneous leishmaniasis patient sera were tested. The cross-reactions were completely abolished by the addition of 0.78% 2-mercaptoethanol to the serum diluent. These data show that this improved DAT can be used for the diagnosis of visceral leishmaniasis in Brazil.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620171

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

1.  Effect of trypsin and 2-mercaptoethanol on the exposure of sugar residues on the surface of Leishmania donovani chagasi.

Authors:  M Auxiliadora; M Santos; P P de Andrade; C R de Andrade; P A Padovan; W de Souza
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas' disease patients.

Authors:  C R de Andrade; L V Kirchhoff; J E Donelson; K Otsu
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 3.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.